Table 1 Comparison of small cell neuroendocrine carcinoma specific biomarkers
From: FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate
Patient ID/tumor location | Chromogranin A | Synaptophysin | FOXA2 |
|---|---|---|---|
Patient #1/Dura | N | P | P |
Patient #1/Liver | N | P | P |
Patient #1/Periaortic LN | N | N | P |
Patient #1/Supraclavicular LN | N | N | P |
Patient #2/RT lung | N | N | P |
Patient #3/Liver | N | P | P |
Patient #4/Periaortic LN | N | P | P |
Patient #5/Liver | N | N | P |
Patent #6/Lung | N | N | N |
SCNC-TMA #1/Prostate | N | N | P |
SCNC-TMA #2/Prostate | P | P | P |
SCNC-TMA #3/Prostate | P | P | P |
SCNC-TMA #4/Prostate | N | N | P |
SCNC-TMA #5/Prostate | P | P | P |
SCNC-TMA #6/Prostate | N | N | P |
SCNC-TMA #7/Prostate | P | P | P |
SCNC-TMA #8/Prostate | N | N | P |
SCNC-TMA #9/Prostate | N | P | P |
SCNC-TMA #10/Prostate | N | P | P |
SCNC-TMA #11/Prostate | P | P | P |
5/20 (25%) | 11/20 (55%) | 19/20 (98%) |